Microbead-assisted retroviral transduction for clinical application

Human Gene Therapy

Volumn 21, Issue 10, 2010, Pages 1335-1342

  Heemskerk, Bianca ^a   Jorritsma, Annelies ^a   Gomez Eerland, Raquel ^a   Toebes, Mireille ^a   Haanen, John B A G ^a   Schumacher, Ton N M ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; RETRONECTIN; UNCLASSIFIED DRUG;

ARTICLE; CELL COUNT; CELL DENSITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORMAL HUMAN; PHENOTYPE; T LYMPHOCYTE; VIRAL GENE DELIVERY SYSTEM; VIRUS PARTICLE;

CELL ADHESION; FIBRONECTINS; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC VECTORS; HUMANS; MICROSPHERES; RECOMBINANT PROTEINS; RETROVIRIDAE; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

MAMMALIA;

EID: 77958109359     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.208     Document Type: Article

References (22)

1. Bordignon, C., Notarangelo, L.D., Nobili, N., Ferrari, G., Ca-sorati, G., Panina, P., Mazzolari, E., Maggioni, D., Rossi, C., Servida, P., Ugazio, A.G., and Mavilio, F. (1995). Gene therapy in peripheral blood lymphocytes and bone marrow for ADA-immunodeficient patients. Science 270, 470-475.
2. Bunnell, B.A., Muul, L.M., Donahue, R.E., Blaese, R.M., and Morgan, R.A. (1995). High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 92, 7739-7743.
3. Cornetta, K. and Anderson, W.F. (1989). Protamine sulfate as an effective alternative to Polybrene in retroviral-mediated gene-transfer: Implications for human gene therapy. J. Virol. Methods 23, 187-194.
4. Culver, K., Cornetta, K., Morgan, R., Morecki, S., Aebersold, P., Kasid, A, Lotze, M., Rosenberg, S.A, Anderson, W.F., and Blaese, R.M. (1991). Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc. Natl. Acad. Sci. U.S.A 88, 3155-3159.
5. Hanenberg, H., Xiao, X.L., Dilloo, D., Hashino, K., Kato, I., and Williams, D.A. (1996). Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat. Med. 2, 876-882.
6. Hollyman, D., Stefanski, J., Przybylowski, M., Bartido, S., Borquez-Ojeda, O., Taylor, C., Yeh, R., Capacio, V., Olszewska, M., Hosey, J., Sadelain, M., Brentjens, R.J., and Riviere, I. (2009). Manufacturing validation of biologically functional T cells targeted to CD19 antigen for autologous adoptive cell therapy. J. Immunother. 32, 169-180.
7. Hwu, P., Yannelli, J., Kriegler, M., Anderson, W.F., Perez, C., Chiang, Y., Schwarz, S., Cowherd, R., Delgado, C., and Mule, J. (1993). Functional and molecular characterization of tumor-infiltrating lymphocytes transduced with tumor necrosis factor-α cDNA for the gene therapy of cancer in humans. J. Immunol. 150, 4104-4115.
8. Jorritsma, A., Gomez-Eerland, R., Dokter, M., Van De Kasteele, W., Zoet, Y.M., Doxiadis, I.I., Rufer, N., Romero, P., Morgan, R.A., Schumacher, T.N., and Haanen, J.B. (2007). Selecting highly affine and well-expressed TCRs for gene therapy of melanoma. Blood 110, 3564-3572.
9. Kotani, H., Newton, P.B., III, Zhang, S., Chiang, Y.L., Otto, E., Weaver, L., Blaese, R.M., Anderson, W.F., AND McGarrity, G.J. (1994). Improved methods of retroviral vector transduction and production for gene therapy. Hum. Gene Ther. 5, 19-28.
10. Lamers, C.H., Willemsen, R.A., Luider, B.A., Debets, R., and Bolhuis, R.L. (2002). Protocol for gene transduction and ex-pansion of human T lymphocytes for clinical immunogene therapy of cancer. Cancer Gene Ther. 9, 613-623.
11. Lamers, C.H., van Elzakker, P., van Steenbergen, S.C., Sleijfer, S., Debets, R., and Gratama, J.W. (2008). RetroNectin-assisted retroviral transduction of primary human T lymphocytes un-der good manufacturing practice conditions: Tissue culture bag critically determines cell yield. Cytotherapy 10, 406-416.
12. Morgan, R.A., Dudley, M.E., Wunderlich, J.R., Hughes, M.S., Yang, J.C., Sherry, R.M., Royal, R.E., Topalian, S.L., Kammula, U.S., Restifo, N.P., Zheng, Z., Nahvi, A., de Vries, C.R., Rogers-Freezer, L.J., Mavroukakis, S.A., and Rosenberg, S.A. (2006). Cancer regression in patients after transfer of geneti-cally engineered lymphocytes. Science 314, 126-129.
13. Moritz, T., Dutt, P., Xiao, X., Carstanjen, D., Vik, T., Hanenberg, H., and Williams, D.A. (1996). Fibronectin improves trans-duction of reconstituting hematopoietic stem cells by retrovi-ral vectors: Evidence of direct viral binding to chymotryptic carboxy-terminal fragments. Blood 88, 855-862.
14. Olsen, J.C., Johnson, L.G., Wong-Sun, M.L., Moore, K.L., Swanstrom, R., and Boucher, R.C. (1993). Retrovirus-mediated gene transfer to cystic fibrosis airway epithelial cells: Effect of selectable marker sequences on long-term expression. Nucleic Acids Res. 21, 663-669.
15. Pollok, K.E., Hanenberg, H., Noblitt, T.W., Schroeder, W.L., Kato, I., Emanuel, D., and Williams, D.A. (1998). High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J. Virol. 72, 4882-4892.
16. Quintas-Cardama, A., Yeh, R.K., Hollyman, D., Stefanski, J., Taylor, C., Nikhamin, Y., Imperato, G., Sadelain, M., Riviere, I., and Brentjens, R.J. (2007). Multifactorial optimization of gammaretroviral gene transfer into human T lymphocytes for clinical application. Hum. Gene Ther. 18, 1253-1260.
17. Rapoport, A.P., Stadtmauer, E.A., Aqui, N., Badros, A., Cotte, J., Chrisley, L., Veloso, E., Zheng, Z., Westphal, S., Mair, R., Chi, N., Ratterree, B., Pochran, M.F., Natt, S., Hinkle, J., Sickles, C., Sohal, A., Ruehle, K., Lynch, C., Zhang, L., Porter, D.L., Luger, S., Guo, C., Fang, H.B., Blackwelder, W., Hankey, K., Mann, D., Edelman, R., Frasch, C., Levine, B.L., Cross, A., and June, C.H. (2005). Restoration of immunity in lymphopenic indi-viduals with cancer by vaccination and adoptive T-cell transfer. Nat. Med. 11, 1230-1237.
18. Schumacher, T.N. (2002). T-cell-receptor gene therapy. Nat. Rev. Immunol. 2, 512-519.
19. Thompson, J.A., Figlin, R.A., Sifri-Steele, C., Berenson, R.J., and Frohlich, M.W. (2003). A phase I trial of CD3/CD28-activated T cells (Xcellerated T cells) and interleukin-2 in patients with metastatic renal cell carcinoma. Clin. Cancer Res. 9,3562-3570.
20. Toebes, M., Coccoris, M., Bins, A., Rodenko, B., Gomez, R., Nieuwkoop, N.J., van de Kasteele, W., Rimmelzwaan, G.F., Haanen, J.B., Ovaa, H., and Schumacher, T.N. (2006). Design and use of conditional MHC class I ligands. Nat. Med. 12, 246-251.
21. Woffendin, C., Ranga, U., Yang, Z., Xu, L., and Nabel, G.J. (1996). Expression of a protective gene-prolongs survival of T cells in human immunodeficiency virus-infected patients. Proc. Natl. Acad. Sci. U.S.A. 93, 2889-2894.
22. Zhou, P., Lee, J., Moore, P., and Brasky, K.M. (2001). High-efficiency gene transfer into rhesus macaque primary T lymphocytes by combining 32 degrees C centrifugation and CH-296-coated plates: Effect of gene transfer protocol on T cell homing receptor expression. Hum. Gene Ther. 12, 1843-1855